Area of research
Hepatology · Epidemiology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Hepatocellular Carcinoma Treatment and Prognosis, Liver Disease and Transplantation, and Hepatitis C virus research.
S3-Leitlinie Diagnostik und Therapie biliärer Karzinome – Langversion
S3-Leitlinie Diagnostik und Therapie biliärer Karzinome – Kurzversion
S3-Leitlinie Diagnostik und Therapie des Hepatozellulären Karzinoms – Langversion
S3-Leitlinie Diagnostik und Therapie des Hepatozellulären Karzinoms – Kurzversion
Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma
S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Langversion 4.0
Elevated serum levels of glial fibrillary acidic protein are associated with covert hepatic encephalopathy in patients with cirrhosis
Validation of the CLIF-C OF Score and CLIF-C ACLF Score to Predict Transplant-Free Survival in Patients with Liver Cirrhosis and Concomitant Need for Intensive Care Unit Treatment
Comparison of Inflammatory Cytokine Levels in Hepatic and Jugular Veins of Patients with Cirrhosis
Higher scores in the Clinical Frailty Scale are associated with covert and overt hepatic encephalopathy in patients with cirrhosis
Development and evaluation of a virtual reality driving test for patients with cirrhosis
Adjuvant <i>nab</i> -Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial
Structured Early detection of Asymptomatic Liver Cirrhosis: Results of the population-based liver screening program SEAL
Evaluation of IL‐6 for Stepwise Diagnosis of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis
Characteristics of bacterial infections and prevalence of multidrug-resistant bacteria in hospitalized patients with liver cirrhosis in Germany
Health literacy in gastrointestinal diseases: a comparative analysis between patients with liver cirrhosis, inflammatory bowel disease and gastrointestinal cancer
Continued alcohol consumption and hepatic encephalopathy determine quality of life and psychosocial burden of caregivers in patients with liver cirrhosis
Validation of EncephalApp_Stroop as screening tool for the detection of minimal hepatic encephalopathy in German patients with liver cirrhosis
Hepatocyte Bcl-3 protects from death-receptor mediated apoptosis and subsequent acute liver failure
Frailty as Tested by the Clinical Frailty Scale Is a Risk Factor for Hepatorenal Syndrome in Patients With Liver Cirrhosis
Liver Frailty Index for Prediction of Short-Term Rehospitalization in Patients with Liver Cirrhosis
S3-Leitlinie: Diagnostik und Therapie des hepatozellulären Karzinoms
S3-Leitlinie: Diagnostik und Therapie biliärer Karzinome
Suppressed serological vitamin A in patients with liver cirrhosis is associated with impaired liver function and clinical detoriation
Acquired Resistance to Antiangiogenic Therapies in Hepatocellular Carcinoma Is Mediated by Yes‐Associated Protein 1 Activation and Transient Expansion of Stem‐Like Cancer Cells
Regorafenib Efficacy After Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Retrospective Study
Risk factors for poorer health literacy in patients with liver cirrhosis
Sonographic assessment of low muscle quantity identifies mortality risk during COVID‐19: a prospective single‐centre study
Elevated serum levels of methylglyoxal are associated with impaired liver function in patients with liver cirrhosis
Association Between Serum Levels of Neurofilament Light Chains and Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis